(Q46914764)

26 December 2017

title

The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer (English)

1 reference

26 December 2017

author

Johanna Tommiska

1

1 reference

26 December 2017

Jiří Lukáš

9

1 reference

26 December 2017

Heli Nevanlinna

15

1 reference

26 December 2017

Carl Blomqvist

11

object named as

Blomqvist C

1 reference

26 December 2017

10

von Smitten K

1 reference

26 December 2017

author name string

Bartkova J

2

1 reference

26 December 2017

Heinonen M

3

1 reference

26 December 2017

Hautala L

4

1 reference

26 December 2017

Kilpivaara O

5

1 reference

26 December 2017

Eerola H

6

1 reference

26 December 2017

Aittomäki K

7

1 reference

26 December 2017

Hofstetter B

8

1 reference

26 December 2017

Ristimäki A

12

1 reference

26 December 2017

Heikkilä P

13

1 reference

26 December 2017

Bartek J

14

1 reference

26 December 2017

language of work or name

English

0 references

publication date

5 November 2007

1 reference

26 December 2017

published in

Oncogene

1 reference

26 December 2017

volume

27

1 reference

26 December 2017

issue

17

1 reference

26 December 2017

page(s)

2501-2506

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210885

exact match

0 references

cites work

DNA damage checkpoints: from initiation to recovery or adaptation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Checking on DNA damage in S phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

DNA damage response as an anti-cancer barrier: damage threshold and the concept of 'conditional haploinsufficiency'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

ATM activation in normal human tissues and testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Triple-negative breast cancer: therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Familial breast cancer in southern Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Cell-cycle checkpoints and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

The role of ATM in breast cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Hallmarks of 'BRCAness' in sporadic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Increased expression of mutant forms of p53 oncogene in primary lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

Altered expression of DNA double‐strand break detection and repair proteins in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

inferred from DOI database lookup

7 January 2021

based on heuristic

Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210885

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1210885

1 reference

26 December 2017

1 reference

26 December 2017